Skip to main content

#151355

Anti-CD21L [R4/23] mAb

Cat. #151355

Anti-CD21L [R4/23] mAb

Cat. #: 151355

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Complement component (3d/Epstein Barr virus) receptor 2; long form (CR2, CD21L)

Class: Monoclonal

Application: IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Jacqueline Cordell

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-CD21L [R4/23] mAb
  • Alternate name: Complement Component (3d/Epstein Barr Virus) Receptor 2; Epstein-Barr Virus Receptor 2; Complement C3d Receptor 3; EBV Receptor 3; C3DR 3; CD21 Antigen; CVID7; SLEB9; CD21; Cr2
  • Research fields: Cell biology;Immunology
  • Clone: R4/23
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB
  • Description: R4/23 recognises the long form of CR2 and can be used to identify dendritic reticulum cells (or their remnants) in lymphoid tissues.
  • Immunogen: Cell lysate from a chronic lymphocytic leukemia patient.
  • Isotype: IgM
  • Myeloma used: P3/NS1/1-Ag4.1

Target Details

  • Target: Complement component (3d/Epstein Barr virus) receptor 2; long form (CR2, CD21L)
  • Target background: CR2 is expressed strongly on mature B cells, follicular dentritic cells and weakly on immature thymocytes and T lymphocytes. CR2 functions as a receptor for C3d, C3dg and iC3b Complement components and for EBV and for IFN alpha. Follicular dendritic cells (contained in B cell follicles) selectively express the Long isoform of CR2 (CD21L) that contains an additional exon (10a) compared to CR2 (CD21).

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Nakamura et al. 1999. Am J Surg Pathol. 23(4):363-76. PMID: 10199466.
  • Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases.
  • Heinen et al. 1984. Eur J Immunol. 14(3):267-73. PMID: 6368249.
  • Isolation of follicular dendritic cells from human tonsils and adenoids. II. Immunocytochemical characterization.
  • Naiem et al. 1983. J Clin Pathol. 36(2):167-75. PMID: 6338047.
  • Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue.
  • Stein et al. 1982. Int J Cancer. 30(4):445-59. PMID: 6754630.
  • Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.